{"id":59954,"date":"2024-02-28T06:25:37","date_gmt":"2024-02-28T06:25:37","guid":{"rendered":"https:\/\/medsname.com\/palip-xr\/"},"modified":"2026-04-30T10:23:52","modified_gmt":"2026-04-30T10:23:52","slug":"palip-xr","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/palip-xr\/","title":{"rendered":"Palip XR"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background:#fff8d6;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<h3 style=\"margin-top:0;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f<\/h3>\n<p style=\"margin-bottom:0;\">Palip XR (Paliperidon 3 \/ 6 \/ 9 mg XR, s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm) je atypick\u00e9 antipsychotikum pro schizofrenii a schizoafektivn\u00ed poruchu. Aktivn\u00ed metabolit risperidonu, pod\u00e1van\u00fd jednou denn\u011b ve form\u011b OROS osmotick\u00e9 tablety. P\u0159ev\u00e1\u017en\u011b vylu\u010dov\u00e1n ledvinami \u2014 upravte d\u00e1vkov\u00e1n\u00ed p\u0159i ren\u00e1ln\u00ed insuficienci.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Palip XR na MedsBase je dod\u00e1v\u00e1n p\u0159\u00edmo od v\u00fdrobce certifikovan\u00e9ho WHO-GMP v jednoduch\u00e9m, diskr\u00e9tn\u00edm balen\u00ed. Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00edm <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a> \u2014 20pracovn\u00edchdenn\u00ed lh\u016fta pro doru\u010den\u00ed, nebo v\u00e1m z\u00e1silku zdarma p\u0159epo\u0161leme \u2014 a oprav\u0148uje v\u00e1s k \u00fa\u010dasti v na\u0161em <a href=\"https:\/\/medsbase.com\/cs\/loyalty-points\/\">v\u011brnostn\u00edm programu<\/a>. Dod\u00e1v\u00e1me do v\u011bt\u0161iny zem\u00ed po cel\u00e9m sv\u011bt\u011b.<\/p>\n<h2>Co je Palip XR a jak funguje<\/h2>\n<p>Palip XR je tableta s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm paliperidonu dod\u00e1van\u00e1 spole\u010dnost\u00ed Sun Pharma. Dostupn\u00e9 s\u00edly: <strong>3 \/ 6 \/ 9 mg XR<\/strong>. Paliperidon je hlavn\u00edm aktivn\u00edm metabolitem risperidonu (9-hydroxyrisperidon). Farmakologicky velmi podobn\u00fd \u2014 siln\u00e1 antagonizace D2 a 5-HT2A receptor\u016f, elevace prolaktinu, EPS p\u0159i vy\u0161\u0161\u00edch d\u00e1vk\u00e1ch \u2014 ale s dv\u011bma praktick\u00fdmi rozd\u00edly: (1) OROS forma s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm vytv\u00e1\u0159\u00ed plochou 24hodinovou k\u0159ivku plazmatick\u00e9 koncentrace (lep\u0161\u00ed sn\u00e1\u0161enlivost ne\u017e risperidon IR) a (2) paliperidon je z v\u011bt\u0161\u00ed \u010d\u00e1sti vylu\u010dov\u00e1n ledvinami (75%) sp\u00ed\u0161e ne\u017e metabolizov\u00e1n j\u00e1try, tak\u017ee nen\u00ed ovlivn\u011bn l\u00e9ky m\u011bn\u00edc\u00edmi CYP, ale vy\u017eaduje \u00fapravu d\u00e1vkov\u00e1n\u00ed p\u0159i ren\u00e1ln\u00ed insuficienci.<\/p>\n<h2>Indikace a d\u00e1vkov\u00e1n\u00ed<\/h2>\n<table>\n<thead>\n<tr>\n<th>Indikace<\/th>\n<th>Po\u010d\u00e1te\u010dn\u00ed d\u00e1vka<\/th>\n<th>C\u00edlov\u00e1 d\u00e1vka<\/th>\n<th>Maxim\u00e1ln\u00ed d\u00e1vka<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Schizofrenie (dosp\u011bl\u00ed)<\/td>\n<td>6 mg 1\u00d7 denn\u011b r\u00e1no<\/td>\n<td>3\u201312 mg 1\u00d7 denn\u011b<\/td>\n<td>12 mg<\/td>\n<\/tr>\n<tr>\n<td>Schizofrenie (dosp\u00edvaj\u00edc\u00ed \u2265 12 let, \u2265 51 kg)<\/td>\n<td>3 mg 1\u00d7 denn\u011b<\/td>\n<td>3\u201312 mg 1\u00d7 denn\u011b<\/td>\n<td>12 mg<\/td>\n<\/tr>\n<tr>\n<td>Schizoafektivn\u00ed porucha<\/td>\n<td>6 mg 1\u00d7 denn\u011b<\/td>\n<td>3\u201312 mg 1\u00d7 denn\u011b<\/td>\n<td>12 mg<\/td>\n<\/tr>\n<tr>\n<td>Ren\u00e1ln\u00ed insuficience (CrCl 50\u201380)<\/td>\n<td>3 mg 1\u00d7 denn\u011b<\/td>\n<td>a\u017e 6 mg<\/td>\n<td>6 mg<\/td>\n<\/tr>\n<tr>\n<td>Ren\u00e1ln\u00ed insuficience (CrCl 10\u201350)<\/td>\n<td>1,5 mg 1\u00d7 denn\u011b<\/td>\n<td>a\u017e 3 mg<\/td>\n<td>3 mg<\/td>\n<\/tr>\n<tr>\n<td>Ren\u00e1ln\u00ed insuficience (CrCl &lt; 10)<\/td>\n<td>nedoporu\u010duje se<\/td>\n<td>\u2014<\/td>\n<td>\u2014<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Polykat cel\u00e9 \u2014 nedrtit, ne\u017ev\u00fdkat ani ned\u011blit. OROS osmotick\u00e1 pumpov\u00e1 ob\u00e1lka bude vylou\u010dena neporu\u0161en\u00e1 ve stolici \u2014 to je norm\u00e1ln\u00ed a o\u010dek\u00e1van\u00e9.<\/p>\n<h2>D\u016fle\u017eit\u00e9 bezpe\u010dnostn\u00ed aspekty<\/h2>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>FDA black-box \u2014 psych\u00f3za spojen\u00e1 s demenc\u00ed<\/strong><\/p>\n<p style=\"margin-bottom:0;\">V\u0161echna atypick\u00e1 antipsychotika nesou varov\u00e1n\u00ed FDA black-box pro zv\u00fd\u0161enou mortalitu (p\u0159edev\u0161\u00edm kardiovaskul\u00e1rn\u00ed a infek\u010dn\u00ed) p\u0159i pou\u017eit\u00ed k l\u00e9\u010db\u011b behavior\u00e1ln\u00edch poruch u star\u0161\u00edch dosp\u011bl\u00fdch s demenc\u00ed. <strong>Atypick\u00e1 antipsychotika nejsou schv\u00e1lena pro psych\u00f3zu nebo agitovanost spojenou s demenc\u00ed<\/strong>. Pou\u017eit\u00ed u t\u00e9to populace je off-label, posledn\u00ed mo\u017enost\u00ed, \u010dasov\u011b omezen\u00e9 a vy\u017eaduje explicitn\u00ed rozhovor o rizic\u00edch a p\u0159\u00ednosech.<\/p>\n<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>Hyperprolaktinemie (podobn\u011b jako risperidon)<\/strong><\/p>\n<p style=\"margin-bottom:0;\">Jako aktivn\u00ed metabolit risperidonu zp\u016fsobuje paliperidon stejn\u00e9 zv\u00fd\u0161en\u00ed prolaktinu: amenorea, galaktorea, sexu\u00e1ln\u00ed dysfunkce a dlouhodob\u00fd \u00fabytek kostn\u00ed denzity. Monitorujte jako u risperidonu; p\u0159i p\u0159\u00edznac\u00edch p\u0159ejd\u011bte na atypikum \u0161et\u0159\u00edc\u00ed prolaktin (aripiprazol, kvetiapin).<\/p>\n<\/div>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>EPS \/ d\u00e1vkov\u011b z\u00e1visl\u00e9<\/strong><\/p>\n<p style=\"margin-bottom:0;\">P\u0159i d\u00e1vk\u00e1ch nad 6 mg\/den se zvy\u0161uje frekvence EPS a akathisie. Z\u00e1visl\u00e9 na d\u00e1vce.<\/p>\n<\/div>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>Upozorn\u011bn\u00ed na gastrointestin\u00e1ln\u00ed obstrukci<\/strong><\/p>\n<p style=\"margin-bottom:0;\">Nedeformovateln\u00e1 OROS tableta je teoreticky problematick\u00e1 u p\u0159edem existuj\u00edc\u00edch z\u00e1va\u017en\u00fdch z\u00fa\u017een\u00ed GI traktu (t\u011b\u017ek\u00e9 striktury u Crohnovy choroby, striktury j\u00edcnu, p\u0159edchoz\u00ed resekce st\u0159eva). Klinicky vz\u00e1cn\u00e9, ale stoj\u00ed za zm\u00ednku.<\/p>\n<\/div>\n<h2>\u010cast\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky<\/h2>\n<ul>\n<li><strong>Hyperprolaktin\u00e9mie a n\u00e1sledn\u00e9 \u00fa\u010dinky<\/strong> \u2014 stejn\u00fd profil jako risperidon.<\/li>\n<li><strong>Akathisie, EPS<\/strong> \u2014 z\u00e1visl\u00e9 na d\u00e1vce.<\/li>\n<li><strong>Ospalost, sedace<\/strong> \u2014 st\u0159edn\u00ed.<\/li>\n<li><strong>P\u0159ib\u00fdv\u00e1n\u00ed na v\u00e1ze<\/strong> \u2014 st\u0159edn\u00ed (2\u20134 kg \/ 6 m\u011bs\u00edc\u016f).<\/li>\n<li><strong>Ortostatick\u00e1 hypotenze<\/strong> \u2014 b\u011b\u017en\u00fd na za\u010d\u00e1tku l\u00e9\u010dby.<\/li>\n<li><strong>Prodlou\u017een\u00ed QT intervalu<\/strong> \u2014 m\u00edrn\u011b z\u00e1visl\u00e9 na d\u00e1vce.<\/li>\n<\/ul>\n<h2>Interakce l\u00e9k\u016f<\/h2>\n<ul>\n<li><strong>M\u00e9n\u011b ovlivn\u011bn inhibitory\/induktory CYP<\/strong> ne\u017e risperidon (75% ren\u00e1ln\u00ed clearance).<\/li>\n<li><strong>L\u00e9ky prodlu\u017euj\u00edc\u00ed QT interval<\/strong> \u2014 aditivn\u00ed riziko.<\/li>\n<li><strong>Antihypertenziva, CNS depresiva, anticholinergika<\/strong> \u2014 t\u0159\u00eddn\u00ed \u00fa\u010dinky aditiv.<\/li>\n<li><strong>Siln\u00e9 induktory CYP3A4 + P-gp<\/strong> (karbamazepin, rifampicin, fenytoin) \u2014 v\u00fdznamn\u00e9 sn\u00ed\u017een\u00ed hladin paliperidonu.<\/li>\n<\/ul>\n<h2>T\u011bhotenstv\u00ed, kojen\u00ed, pediatrie<\/h2>\n<p>T\u011bhotenstv\u00ed: omezen\u00e1 data; expozice v pozdn\u00edm t\u011bhotenstv\u00ed m\u016f\u017ee zp\u016fsobit neonat\u00e1ln\u00ed EPS. Kojen\u00ed: p\u0159ech\u00e1z\u00ed do ml\u00e9ka; obvykle vy\u017eaduje monitorov\u00e1n\u00ed. Pediatrie: schv\u00e1leno od 12 let (schizofrenie, \u2265 51 kg).<\/p>\n<h2>Skladov\u00e1n\u00ed<\/h2>\n<p>Skladujte p\u0159i 15\u201330 \u00b0C v p\u016fvodn\u00edm obalu.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>Jak se Palip XR li\u0161\u00ed od risperidonu?<\/h3>\n<p>Paliperidon je hlavn\u00edm aktivn\u00edm metabolitem risperidonu \u2014 jsou farmakologicky podobn\u00e9. Dva praktick\u00e9 rozd\u00edly: (1) jednodenn\u00ed d\u00e1vkov\u00e1n\u00ed OROS vytv\u00e1\u0159\u00ed plo\u0161\u0161\u00ed plazmatick\u00e9 hladiny a lep\u0161\u00ed sn\u00e1\u0161enlivost ne\u017e BID risperidon IR; (2) paliperidon je z velk\u00e9 \u010d\u00e1sti vylu\u010dov\u00e1n ledvinami, tak\u017ee nen\u00ed ovlivn\u011bn l\u00e9ky interaguj\u00edc\u00edmi s CYP, ale vy\u017eaduje \u00fapravu d\u00e1vkov\u00e1n\u00ed podle funkce ledvin.<\/p>\n<h3>Pro\u010d se v m\u00e9 stolici objevuje pr\u00e1zdn\u00e1 tabletov\u00e1 sko\u0159\u00e1pka?<\/h3>\n<p>OROS tableta (osmotic-controlled-release oral delivery system) je nedeformovateln\u00e1 sko\u0159\u00e1pka obsahuj\u00edc\u00ed l\u00e9\u010divo v semipermeabiln\u00ed membr\u00e1n\u011b. Voda vstupuje pomalu a vytla\u010duje l\u00e9\u010divo p\u0159es laserem vytvo\u0159en\u00fd otvor. Pr\u00e1zdn\u00e1 sko\u0159\u00e1pka proch\u00e1z\u00ed neporu\u0161en\u00e1 \u2014 to je sou\u010d\u00e1st designu, nikoli probl\u00e9m. Nep\u0159est\u00e1vejte u\u017e\u00edvat l\u00e9k z tohoto d\u016fvodu.<\/p>\n<h3>Je jednodenn\u00ed LAI jin\u00fd ne\u017e peror\u00e1ln\u00ed tableta?<\/h3>\n<p>Paliperidon palmit\u00e1t (Invega Sustenna m\u011bs\u00ed\u010dn\u011b, Trinza t\u0159\u00edm\u011bs\u00ed\u010dn\u011b, Hafyera \u0161est m\u011bs\u00ed\u010dn\u011b) je depotn\u00ed injek\u010dn\u00ed LAI. Peror\u00e1ln\u00ed tableta je ur\u010dena k zah\u00e1jen\u00ed l\u00e9\u010dby, titraci a pacient\u016fm, kte\u0159\u00ed preferuj\u00ed peror\u00e1ln\u00ed terapii. LAI je samostatn\u00fd produkt s vlastn\u00edm d\u00e1vkov\u00e1n\u00edm.<\/p>\n<h3>Ovlivn\u00ed Palip XR mou plodnost?<\/h3>\n<p>Zv\u00fd\u0161en\u00ed prolaktinu zp\u016fsoben\u00e9 paliperidonem m\u016f\u017ee potla\u010dit plodnost u mu\u017e\u016f i \u017een. V\u011bt\u0161ina \u00fa\u010dink\u016f je reverzibiln\u00ed po vysazen\u00ed. Pokud pl\u00e1nujete t\u011bhotenstv\u00ed, proberte p\u0159echod na aripiprazol nebo kvetiapin.<\/p>\n<h3>Za jak dlouho za\u010dne Palip XR p\u016fsobit?<\/h3>\n<p>Akutn\u00ed \u00fa\u010dinek na agitaci b\u011bhem dn\u016f. Antipsychotick\u00fd \u00fa\u010dinek na pozitivn\u00ed p\u0159\u00edznaky 1\u20132 t\u00fddny; pln\u00fd \u00fa\u010dinek za 4\u20136 t\u00fddn\u016f.<\/p>\n<h3>Mohu tabletu rozd\u011blit nebo rozdrtit?<\/h3>\n<p>Ne \u2014 nikdy. Formulace OROS s osmotick\u00fdm \u010derpadlem z\u00e1vis\u00ed na neporu\u0161en\u00e9 tablet\u011b. Rozdrcen\u00ed nebo rozd\u011blen\u00ed ni\u010d\u00ed \u0159\u00edzen\u00e9 uvol\u0148ov\u00e1n\u00ed a zp\u016fsob\u00ed okam\u017eit\u00e9 uvoln\u011bn\u00ed d\u00e1vky.<\/p>\n<h3>A co \u0159\u00edzen\u00ed pod vlivem Palip XR?<\/h3>\n<p>Sedace je m\u00edrn\u00e1 a soust\u0159ed\u011bn\u00e1 v prvn\u00edch 1\u20132 t\u00fddnech. V\u011bt\u0161ina pacient\u016f na stabiln\u00ed d\u00e1vce m\u016f\u017ee norm\u00e1ln\u011b \u0159\u00eddit. P\u0159i \u0159\u00edzen\u00ed se vyhn\u011bte alkoholu.<\/p>\n<h3>Zp\u016fsob\u00ed Palip XR p\u0159ib\u00edr\u00e1n\u00ed na v\u00e1ze?<\/h3>\n<p>Ano \u2014 obvykle 2\u20134 kg za 6 m\u011bs\u00edc\u016f. M\u00e9n\u011b ne\u017e olanzapin nebo kvetiapin; podobn\u011b jako risperidon.<\/p>\n<h3>Lze Palip XR n\u00e1hle vysadit?<\/h3>\n<p>Postupn\u00e9 sni\u017eov\u00e1n\u00ed d\u00e1vky po dobu 2\u20134 t\u00fddn\u016f. Hlavn\u00edm rizikem je relaps u schizofrenie a schizoafektivn\u00ed poruchy.<\/p>\n<h3>Pro\u010d je Palip XR vhodn\u011bj\u0161\u00ed p\u0159i onemocn\u011bn\u00ed jater ne\u017e risperidon?<\/h3>\n<p>Paliperidon je z v\u011bt\u0161\u00ed \u010d\u00e1sti vylu\u010dov\u00e1n ledvinami (75%) a ne metabolizov\u00e1n j\u00e1try \u2014 je tedy m\u00e9n\u011b ovlivn\u011bn jatern\u00edm po\u0161kozen\u00edm a l\u00e9ky ovliv\u0148uj\u00edc\u00edmi CYP syst\u00e9m. Nev\u00fdhodou je nutnost \u00fapravy d\u00e1vky p\u0159i ren\u00e1ln\u00edm posti\u017een\u00ed, co\u017e u risperidonu neplat\u00ed.<\/p>\n<h2>Dal\u0161\u00ed l\u00e9ky na du\u0161evn\u00ed zdrav\u00ed<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/aripicon\/\">Aripicon (Aripiprazol \u2014 parci\u00e1ln\u00ed agonista D2)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/olanzap\/\">Olanzap (Olanzapin \u2014 \u00fa\u010dinn\u00e9 antipsychotikum)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/risdone\/\">Risdone (Risperidon)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/seroquit\/\">Seroquit (Quetiapin \u2014 bipol\u00e1rn\u00ed deprese)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/atlura\/\">Atlura (Lurasidon \u2014 metabolicky neutr\u00e1ln\u00ed)<\/a><\/li>\n<\/ul>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;font-size:0.9em;\">\n<strong>Zdravotn\u00ed prohl\u00e1\u0161en\u00ed.<\/strong> Tato str\u00e1nka m\u00e1 vzd\u011bl\u00e1vac\u00ed charakter a nenahrazuje individu\u00e1ln\u00ed l\u00e9ka\u0159skou radu. Farmakoterapie du\u0161evn\u00edho zdrav\u00ed by m\u011bla b\u00fdt zah\u00e1jena, monitorov\u00e1na a upravov\u00e1na pod dohledem kvalifikovan\u00e9ho l\u00e9ka\u0159e. Pokud vy nebo n\u011bkdo, koho zn\u00e1te, pro\u017e\u00edv\u00e1 sebevra\u017eednou krizi, okam\u017eit\u011b kontaktujte m\u00edstn\u00ed z\u00e1chrann\u00e9 slu\u017eby nebo volejte linku prevence sebevra\u017ed ve va\u0161\u00ed zemi (USA\/Kanada: 988; UK: Samaritans 116 123; mezin\u00e1rodn\u00ed seznam: <a href=\"https:\/\/findahelpline.com\/\" rel=\"nofollow noopener\" target=\"_blank\">findahelpline.com<\/a>).\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Palip XR (Paliperidon 3\/6\/9 mg XR) \u2014 atypick\u00e9 antipsychotikum s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm OROS pro schizofrenii a schizoafektivn\u00ed poruchu. Pod\u00e1v\u00e1 se jednou denn\u011b, vylu\u010dov\u00e1n ledvinami \u2014 nen\u00ed ovlivn\u011bn l\u00e9ky m\u011bn\u00edc\u00edmi CYP.<\/p>","protected":false},"featured_media":59955,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3342,3906],"product_tag":[4774,4775],"class_list":{"0":"post-59954","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-general-health","8":"product_cat-mental-health-and-psychiatric-medications","9":"product_tag-palip-xr","10":"product_tag-paliperidone","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/59954","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=59954"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/59955"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=59954"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=59954"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=59954"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=59954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}